NRW.BANK invested 3500000 EUR through its venture capital fund NRW.Venture. The company is based at the Biomedizin Zentrum Dortmund.
About IDEL Therapeutics
iDEL Therapeutics is a biotechnology startup developing a drug delivery system that transports therapeutics directly into cancer cells to improve cancer treatment efficacy and reduce side effects.
Dortmund, Germany
Read Company ProfileFrequently Asked Questions
What type of funding round did IDEL Therapeutics raise?
IDEL Therapeutics raised a seed round.
How much did IDEL Therapeutics raise in its seed?
IDEL Therapeutics raised $9,000,000 EUR in its seed.
When did IDEL Therapeutics raise its seed?
IDEL Therapeutics raised its seed on 2026-03-17.
Who invested in IDEL Therapeutics's seed?
The investors in IDEL Therapeutics's seed are: BiomedVC, Gründerfonds Ruhr, KHAN Technology Transfer Fund-II, NRW.BANK.
What type of investment was IDEL Therapeutics's seed?
IDEL Therapeutics's seed was a equity investment.
How will IDEL Therapeutics use the funds from its seed?
IDEL Therapeutics plans to use the funds for: create the prerequisites for clinical evaluation of the technology, extend runway, advance preclinical proof-of-concept of the pan-cancer platform.